Protein Kinase C in Cell Growth and Differentiation

  • J. F. Kuo
  • M. Shoji
  • Z. Kiss
  • P. R. Girard
  • E. Deli
  • K. Oishi
  • W. R. Vogler
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 255)


It has been shown that human promyelocytic leukemia cell line HL601 and acute myeloblastic leukemia cell line KG-12 can be induced to terminally differentiate to macrophage-like cells by 12-0-tetradecanoylphorbol-13-acetate (TPA). Because TPA is a potent activator of protein kinase C (PKC) and the enzyme is the only known high affinity receptor for the tumor promoter3, it is likely that the TPA effects are PKC-dependent. TPA, however, is ineffective in inducing differentiation of a HL60 subline HL60BII4 and a KG-1 subline KG-1a5. The molecular mechanisms underlying the responsiveness or resistance to the differentiating effect of TPA remain unclear. The density and affinity of cell surface receptors for phorbol ester appear to be uninvolved, because there are no significant differences in the binding properties of phorbol ester between KG-1 and KG-1a cells6 or between HL60 and HL60BII cells4. The post-receptor events that occur after binding of TPA to the plasma membrane PKC, which might be distinct for the sublines, perhaps are critical in determining the sensitivity of cells to the differentiating effect of TPA. In this paper we summarize our recent studies on the PKC system in these and other cell lines as well as in developing nervous tissues, aiming to elucidate a role of PKC in cell growth and differentiation.


HL60 Cell Phorbol Ester Differentiate Effect HL60 Cell Differentiation Human Promyelocytic Leukemia Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E. Huberman, and M.F. Callahan, Proc. Natl. Acad. Sci. U.S.A. 76: 293–297 (1979).CrossRefGoogle Scholar
  2. 2.
    H.P. Koeffler, M. Bar-Eli, and M.C. Territo, Cancer Res. 41: 919–926 (1981).PubMedGoogle Scholar
  3. 3.
    Y. Nishizuka, Nature (London) 308: 693–698 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    J.B. Weinberg, M.A. Misukonis, and B.J. Goodwin, Cancer Res. 44: 976–980 (1984).PubMedGoogle Scholar
  5. 5.
    H.P. Koeffler, P. Billing, A.J. Lusis, R. Sparkes, and D.W. Golde, Blood, 56: 265–273 (1980).PubMedGoogle Scholar
  6. 6.
    R.I. Lehrer, L.E. Cohen, and H.P. Koeffler, Cancer Res., 43: 3563–3566 (1983).PubMedGoogle Scholar
  7. 7.
    M. Shoji, P.R. Girard, P.A. Charp, H.P. Koeffler, W.R. Vogler, and J.F. Kuo, Cancer Res. 47: 6363–6370 (1987).PubMedGoogle Scholar
  8. 8.
    M. Shoji, P.R. Girard, G.J. Mazzei, W.R. Vogler, and J.F. Kuo, Biochem. Biophys. Res. Commun. 135: 1144–1149 (1986).PubMedCrossRefGoogle Scholar
  9. 9.
    P.R. Girard, V.L. Stevens, P.J. Blackshear, A.L. Merrill, J.G. Wood, and J.F. Kuo, Cancer Res. 47: 2892–2898 (1987).PubMedGoogle Scholar
  10. 10.
    D.L. Halsey, P.R. Girard, J.F. Kuo, and P.J. Blackshear, J. Biol. Chem., 262: 2234–2243 (1987).PubMedGoogle Scholar
  11. 11.
    B.C. Courcelles, P. Roevens, and H. Van Belle, J. Biol. Chem., 260: 15762–15770 (1985).Google Scholar
  12. 12.
    Z. Kiss, E. Deli, M. Shoji, H.P. Koeffler, G.R. Pettit, W.R. Vogler, and J.F. Kuo, Cancer Res., 47: 1302–1307 (1987).PubMedGoogle Scholar
  13. 13.
    D. Kreutter, A.B. Caldwell, and M.J. Morin, J. Biol. Chem., 260: 5979–5984 (1985).PubMedGoogle Scholar
  14. 14.
    A.H. Merrill, A.M. Sereni, V.L. Stevens, Y.A. Hannun, and R.M. Bell, J. Biol. Chem., 261: 12610–12615 (1986).PubMedGoogle Scholar
  15. 15.
    S. Capitani, P.R. Girard, G.J. Mazzei, Kou, J.F., Berezney, R., and F.A. Manzoli, Biochem. Biophys. Res. Commun., 142: 367–375 (1987).PubMedCrossRefGoogle Scholar
  16. 16.
    J.G. Wood, P.R. Girard, G.J. Mazzei, and J.F. Kuo, J. Neurosci., 6: 2571–2577 (1986).PubMedGoogle Scholar
  17. 17.
    Z. Kiss, E. Deli, and J.F. Kuo, FEBS Lett., 231: 41–46 (1988).PubMedCrossRefGoogle Scholar
  18. 18.
    N. Sahyoun, N. Wolf, J. Besterman, T.S. Hsieh, M. Sander, H. Levine, K.J. Chang, and P. Cuatrecasas, Proc. Natl. Acad. Sci. U.S.A., 83: 1603–1607 (1986).PubMedCrossRefGoogle Scholar
  19. 19.
    L.F. Chung, R.H. Cooper, P. Yau, E.M. Bradbury, and R.Y. Chuang, Biochem. Biophys. Res. Comun., 145: 1376–1383 (1987).CrossRefGoogle Scholar
  20. 20.
    A.P. Fields, G.R. Pettit, and W.S. May, J. Biol. Chem., 263: 8253–8260 (1988).PubMedGoogle Scholar
  21. 21.
    Z. Kiss, E. Deli, and J.F. Kuo, Biochem. J., 248: 649–656 (1987).PubMedGoogle Scholar
  22. 22.
    R.A. Cooper, A.K. Braunwald, and A.L. Kuo, Proc. Natl. Acad. Sci. U.S.A., 79: 2865–2869 (1982).PubMedCrossRefGoogle Scholar
  23. 23.
    Z. Kiss, E. Deli, and J.F. Kuo, Arch. Biochem. Biophys., 265: 000–000 (1988), in press.CrossRefGoogle Scholar
  24. 24.
    E. Deli, Z. Kiss, and J.F. Kuo, FEBS Lett., 231: 407–412 (1988).PubMedCrossRefGoogle Scholar
  25. 25.
    S.J. Collins, F.W. Ruscetti, R.B. Gallagher, and R.C. Gallo, Proc. Natl. Acad. Sci. U.S.A., 75: 2458–2462 (1978).PubMedCrossRefGoogle Scholar
  26. 26.
    T.R. Breitman, S.E. Selonick, and S.J. Collins, Proc. Natl. Acad. Sci. U.S.A., 77: 2936–2940 (1980).PubMedCrossRefGoogle Scholar
  27. 27.
    T.J. Chaplinski, and J.E. Niedel, J. Clin. Invest. 70: 953–964 (1982).PubMedCrossRefGoogle Scholar
  28. 28.
    A. Yen, M. Forbes, G. DeGala, and J. Fishbaugh, Cancer Res., 47: 129–134 (1982).Google Scholar
  29. 29.
    E. Fibach, T. Peled, A. Treves, A. Kornberg, and E. Rachmilewitz, Leukemia Res., 6: 781–790 (1982).CrossRefGoogle Scholar
  30. 30.
    P.R. Girard, J.G. Wood, J.E. Freschi, and J.F. Kuo, Develop. Biol., 126: 98–107 (1988).PubMedCrossRefGoogle Scholar
  31. 31.
    W.E. Berdel, R. Andreesen, and P.G. Munder, Synthetic alkyl-phospholipids analogs: A new class of antitumor agents, in: “Phospholipids and Cellular Regulation”, vol. 2, J.F. Kuo, ed., CRC Press, Boca Raton, pp. 41–74 (1985).Google Scholar
  32. 32.
    Z. Kiss, E. Deli, W.R. Vogler, and J.F. Kuo, Biochem. Biophys. Res. Commun., 142: 661–666 (1987).PubMedCrossRefGoogle Scholar
  33. 33.
    K. Oishi, R.L. Raynor, P.A. Charp, and J.F. Kuo, J. Biol. Chem., 263: 6865–6871 (1988).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • J. F. Kuo
    • 1
  • M. Shoji
    • 2
  • Z. Kiss
    • 1
  • P. R. Girard
    • 1
  • E. Deli
    • 1
  • K. Oishi
    • 1
  • W. R. Vogler
    • 2
  1. 1.Departments of PharmacologyEmory University School of MedicineAtlantaUSA
  2. 2.Departments of Medicine (Hematology/Oncology)Emory University School of MedicineAtlantaUSA

Personalised recommendations